The algorithm that entered everyday practice: how the UC Health system improved blood pressure control in tens of thousands of patients
High blood pressure has for years belonged to the group of the most widespread and most dangerous chronic health problems in the United States. It is a condition that often develops quietly, without pronounced symptoms, but with very concrete consequences: it increases the risk of stroke, heart attack, heart failure, kidney disease, and a series of other complications. That is precisely why new research within the University of California Health system is attracting great attention from the professional public. According to data published by UC San Francisco and the journal
BMJ Open Quality, a unique clinical algorithm for the treatment of hypertension, introduced in all six academic medical centers of the California university system, led to a measurable improvement in blood pressure control in approximately 90,000 patients. The effect did not remain only in statistics, but according to the researchers’ estimates also translates into prevented severe outcomes, including strokes, heart attacks, and deaths.
The study titled
Scalable treatment algorithm focused on hypertension management for the University of California was published on March 18, 2026, in the journal
BMJ Open Quality. The paper describes how the UC Health system developed and introduced a standardized therapeutic approach called the
UC Way Hypertension Medication Algorithm, with the aim of reducing differences in treatment between individual institutions, making decision-making easier for physicians, and at the same time taking into account the cost of therapy and the needs of different patient groups. According to the published results, the hypertension control rate increased from 68.5 to almost 74 percent. The authors estimate that this means about 4,860 additional patients with controlled blood pressure, which is associated with an estimated 72 prevented strokes, 48 prevented heart attacks, and 38 prevented deaths.
Why this is an important step forward
The value of this approach is not only in the improvement of the numbers themselves, but in the fact that it was developed and implemented at the level of an entire large public academic health system. UC Health includes six academic medical centers and more than 9 million outpatient visits annually, and such large and complex systems often have the problem of uneven care. Guidelines for hypertension have existed for years, but in practice implementation often depends on the institution, the physician, the availability of medications, prescribing habits, and the possibilities of digital support. The authors of the study emphasize that their goal was to reduce precisely this variability, that is, to introduce a shared, evidence-based treatment model that can be adapted to local practice but does not lose the basic logic of standardized care.
According to the paper’s abstract and the official UC San Francisco press release, the development of the program began in 2020, when multidisciplinary teams brought together cardiologists, internists, family medicine physicians, nurses, pharmacists, and data experts. Such a composition is not accidental. Hypertension is not a problem solved by just one prescription or one examination, but by a combination of pharmacological treatment, monitoring, education, and system organization. The program was introduced across the entire system in 2023, and was then monitored through a two-year period that ended in mid-2025.
How the UC Way algorithm works
The very core of the program is not spectacular technology in the sense of a black box or autonomous decision-making, but a standardized algorithm for selecting and intensifying therapy. This means that, through predefined steps, the physician receives a structured path by which the number and dose of medications can be increased, but with the possibility of adapting to the individual circumstances of the patient. The official description states that the algorithm also includes special adjustments for specific groups, for example older people, and that it is integrated into the electronic health record. In other words, the tool is not conceived as a separate document that stands on the side, but as part of everyday clinical work.
The authors of the paper particularly emphasize one more dimension: the affordability of therapy. In the American healthcare system, the price of medications and the mode of insurance often strongly affect whether the patient will actually receive the therapy the physician recommends. For that reason, the algorithm was developed with an emphasis on cost-effective options and the use of combination therapies when that is clinically justified. This is an attempt to ensure that treatment does not remain only a theoretical ideal, but is feasible in real conditions, including different insurance models and different patient profiles.
It is important to point out that such an approach does not mean automated treatment without physician assessment. On the contrary, the study and the accompanying statements by the researchers show that it is a tool that reduces arbitrary differences and reminds clinicians of an evidence-based sequence of steps, but leaves room for the clinician to adapt therapy to the specific patient. It is precisely this combination of standardization and individualization that explains why the authors present the algorithm as a model that can be expanded to other healthcare systems.
What the numbers say about the scale of the problem
The broader context further explains why such an intervention has public health weight. The U.S. Centers for Disease Control and Prevention state that almost half of adults in the United States, or about 119.9 million people, have high blood pressure. At the same time, disease control remains insufficient: according to the same data, only about 22.5 percent of adults with high blood pressure have the condition under control. The CDC also states that high blood pressure in 2023 was the primary or contributing cause of 664,470 deaths in the United States. These data show two things. First, this is one of the largest chronic burdens on the healthcare system. Second, the room for improvement is not marginal, but enormous.
Hypertension is particularly dangerous because it can remain unrecognized or underestimated for a long time. The consequences are often seen only when a serious cardiovascular event or organ damage occurs. That is why programs that standardize early and consistent treatment are especially important. In practice, a system that more easily brings a patient to target blood pressure does not only reduce the likelihood of future hospitalization, but also the long-term costs of treatment, the number of emergency situations, and the burden of disability that arises after a stroke or heart attack.
Inequalities remain a major challenge
One of the most important elements of this study is the issue of health inequalities. Researchers from UC Health explicitly state that the problem of hypertension is particularly pronounced in some populations, including Black and Hispanic adults. The official UC San Francisco press release highlighted that hypertension control among Black patients increased from 63.4 to 67.3 percent. This is significant progress, but the authors simultaneously warn that the differences have not disappeared and that more targeted interventions are needed.
Official data from the U.S. Office of Minority Health further confirm the seriousness of inequality. According to that institution, Black adult Americans in 2024 were 26 percent more likely to have diagnosed hypertension than the overall U.S. adult population, and from 2017 to 2020, people from that group with hypertension were 18 percent less likely to have their blood pressure under control compared with the overall population with the same diagnosis. The CDC also states that hypertension is more common among non-Hispanic Black adults than among White, Asian, and Hispanic adults. All of this means that a systemic tool, however useful it may be, does not by itself erase the social, economic, and organizational differences that shape health outcomes.
This is precisely where one of the important messages of this study lies. Standardization can reduce part of the differences that arise within the care system, for example because of different patterns of prescribing therapy or a different pace of treatment intensification. But it cannot by itself solve barriers such as poorer access to healthcare, unfavorable living conditions, lower availability of quality nutrition, distrust of institutions, or the greater financial burden of treatment. That is why the authors do not present UC Way as a final solution, but as an important step that has shown that the system can move in a better direction.
What researchers cite as the key to success
The statement by the lead author, physician and professor of medicine Sandeep P. Kishore of UC San Francisco, summarizes the main idea of the paper: the problem is not that medicine does not know how to control blood pressure, but that healthcare systems often fail to consistently apply what is already known. In that sense, this study does not bring a sensationalist claim about a new drug or a revolutionary discovery, but shows how important the organization of care can be just as much as the therapy itself. If physicians in a large system have a clear, embedded, evidence-supported, and financially considered therapeutic path, there is a greater likelihood that the patient will more quickly reach the appropriate combination of medications and more stable control of the disease.
This is especially important in chronic diseases, where a large part of the loss occurs not because treatment does not exist, but because implementation is insufficiently fast, uneven, or incomplete. Hypertension is a classic example of such a problem. Patients can spend years circulating between occasional checkups, dose changes, and insufficiently aggressive therapeutic escalation. The introduction of an algorithm that structures decisions and reduces hesitation when adjusting therapy can therefore have a very concrete effect at the population level.
What this means for other healthcare systems
One of the more important questions after the publication of the study is whether a similar model can be transferred beyond the California university system. The researchers believe that it can, although with adaptation to local conditions. Their argument is not that all healthcare systems are the same, but that the fundamental problem of uneven treatment of hypertension exists almost everywhere. Where there is an electronic health record, team-based work organization, and management willingness to introduce shared clinical pathways, a similar algorithm could help standardize care. It is especially important that the authors do not start from an idealized environment, but from a complex multi-payer model characteristic of American healthcare.
For European observers, it is also interesting that the focus is on the organization of the system, and not only on the individual physician. In public debates about healthcare, the emphasis is often placed on staff shortages or rising costs, while the issue of standardizing clinical decisions remains in the background. This study shows that the digital integration of guidelines and therapeutic algorithms can bring measurable progress even without spectacularly new medications. In other words, innovation is sometimes not in a new molecule, but in finally embedding existing knowledge consistently into practice.
Alongside medications, researchers also remind us of the basics
Although the focus of the paper is on the therapeutic algorithm, the researchers do not neglect the basic lifestyle habits that affect blood pressure. In the accompanying press release, recommendations considered standard in the professional literature were highlighted: quitting smoking and tobacco use, limiting alcohol, reducing salt intake, regular physical activity, reducing body weight in people who are overweight, a balanced diet, and home blood pressure measurement using validated devices. Such recommendations are not new in themselves, but they remain crucial because hypertension in a large number of cases arises from a combination of biological, social, and lifestyle factors.
It is important, however, to note that the study does not try to replace lifestyle habits with pharmacology nor vice versa. Its message is that successful treatment requires both levels: the patient must have clear lifestyle recommendations, but also timely, accessible, and systematically guided medication-supported treatment when it is needed. It is precisely the combination of these elements that in practice gives the best prospects for stable control of hypertension.
Next step: diabetes
The authors and UC San Francisco announce that a similar approach is already being developed for diabetes. This is a logical continuation, because it is another chronic disease in which a large part of outcomes depends on consistent monitoring, timely intensification of therapy, and coordination between different parts of the healthcare system. If the model introduced for hypertension shows long-term sustainability, it could serve as a template for a broader redesign of chronic disease management.
That is also the broadest value of this story. The study on the UC Way program is not only a report on better blood pressure control in one hospital network. It is also a reminder that public health depends not only on scientific discoveries, but also on the ability of the system to translate existing knowledge into everyday, consistent, and fairer practice. At a time when almost 120 million adult Americans live with high blood pressure, every model that manages to improve disease control at the level of tens of thousands of patients becomes important for physicians, healthcare administrators, and patients themselves. If the results are confirmed in other settings, UC Way could be remembered less as a local California project and more as an example of how organizational discipline in medicine can save real lives.
Sources:- UC San Francisco – official press release on the results of the UC Way program and the estimated effects on the number of strokes and heart attacks as well as deaths (link)
- BMJ Open Quality – abstract and bibliographic data of the study on the UC Way Hypertension Medication Algorithm published on March 18, 2026 (link)
- CDC – official facts and statistics on high blood pressure in the United States, including prevalence, disease control, and mortality (link)
- U.S. Office of Minority Health – data on hypertension among Black/African American adults and indicators of inequality in disease control (link)
Find accommodation nearby
Creation time: 4 hours ago